The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients

Leukemia & Lymphoma
B SavoldoCliona M Rooney

Abstract

Epstein-Barr Virus Lymphoproliferative Diseases (EBV-LPD) can affect patients receiving allogeneic hemopoietic stem cell or solid organ transplant. They are caused by impairment of EBV specific CD8+ cytotoxic T-lymphocyte (CTL) response due to the immunosuppression that follows these procedures. Despite different therapies LPD can still have a rapid and lethal course. A promising solution is the application of adoptive immunotherapy approaches such as ex vivo generated EBV-specific CTLs for prevention and therapy. Their infusion has been demonstrated to be safe and effective in allogeneic hemopoietic stem cell transplant recipients and their use after allogeneic solid organ transplant is also under evaluation.

References

May 1, 1985·Transplantation·D W HantoR L Simmons
Feb 5, 1994·Lancet·G Niedobitek, L S Young
Sep 8, 1994·The New England Journal of Medicine·H E HeslopC M Rooney
Dec 1, 1996·American Journal of Respiratory and Critical Care Medicine·R M ArisJ Handy
Jan 1, 1997·Annual Review of Immunology·A B Rickinson, D J Moss
Jun 1, 1997·Immunological Reviews·H E Heslop, C M Rooney
Aug 1, 1997·The Journal of Pediatrics·G J BoyleF J Fricker
Oct 23, 1997·Hematology/oncology Clinics of North America·L J Swinnen
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V LeblondM Raphael
Oct 13, 1998·Immunity·G J BabcockD A Thorley-Lawson
Jun 17, 1999·Nature Medicine·D A Cooper, S Emery
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·R KhannaD J Moss
Nov 24, 1999·Lancet·D TeichmannN Suttorp

❮ Previous
Next ❯

Citations

Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Philip SavageAgamemnon Epenetos
Aug 11, 2001·Current Opinion in Immunology·J M BrownJ A Shizuru
Dec 17, 2002·Critical Reviews in Oncology/hematology·Jaap M MiddeldorpChris J L M Meijer
Mar 13, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Erin R Steenblock, Tarek M Fahmy
Mar 9, 2012·Clinical & Developmental Immunology·Trudy StraetemansReno Debets
May 8, 2007·International Journal of Hematology·Keisei KawaMasami Inoue
Mar 22, 2005·Bone Marrow Transplantation·J J Auletta, H M Lazarus
Jun 30, 2009·Transplant Infectious Disease : an Official Journal of the Transplantation Society·J StyczynskiP Ljungman
Apr 1, 2006·Pediatric Transplantation·Kenneth G Lucas, Qi Sun
Jun 30, 2004·Blood Cells, Molecules & Diseases·Laurence J N CooperMichael C Jensen
Sep 27, 2005·Cellular Immunology·Beate R BernerDonald D Anthony
Jun 13, 2015·PLoS Pathogens·Chiara RancanAndreas Moosmann
Jan 9, 2003·The Journal of Laboratory and Clinical Medicine·Steven M DevineJohn F DiPersio
Feb 4, 2010·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Glenda Mary Davison
Jun 28, 2005·Critical Reviews in Oncology/hematology·Anna L TaylorJ Andrew Bradley
Apr 20, 2004·Journal of Hepatology·Véronique Leblond, Sylvain Choquet
Jun 18, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander ClaviezWolfgang Dörffel
Mar 10, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony T C ChanRichard F Ambinder
Apr 3, 2004·Nature Biotechnology·Jiyun V KimMichel Sadelain
Jan 29, 2008·International Journal of Cancer. Journal International Du Cancer·Carolin LükingRalph Mocikat
May 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zsolt SebestyénReno Debets
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jooeun BaeHans G Klingemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.